Originally developed with GlaxoSmithKline, ofatumumab was first approved by regulators to treat chronic lymphocytic leukaemia under the brand name Arzerra. But after acquiring the drug through an ...

Donald Trump has said he cannot rule out insider trading by his staff after his tariff announcements triggered huge stock ...